Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
T1D Exchange Biobank Resource Report Resource Website 1+ mentions |
T1D Exchange Biobank (RRID:SCR_017195) | biobank, data or information resource, material storage repository, service resource, storage service resource | Collection of biological samples linked to participant medical data from individuals living with type 1 diabetes. Unifies samples and data from eight different clinical studies related to type 1 diabetes. | collection, biological, sample, data, clinical, diabetes |
is related to: Type 1 Diabetes Knowledge Portal has parent organization: T1D Exchange |
Type 1 diabetes, Diabetes | Restricted | SCR_017195 | 2026-09-03 04:54:22 | 2 | |||||||||
|
Integrated Islet Distribution Program (IIDP) Resource Report Resource Website 100+ mentions Rating or validation data |
Integrated Islet Distribution Program (IIDP) (RRID:SCR_014387) | IIDP | data or information resource, organization portal, portal, resource | The goal of the Integrated Islet Distribution Program (IIDP) is to work with the leading islet isolation centers in the U.S. to distribute high quality human islets to the diabetes research community, in order to advance scientific discoveries and translational medicine. | program, islet, distribution, diabetes |
is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Research Resources |
Diabetes | NIDDK | http://www.niddk.nih.gov/research-funding/research-resources/Pages/default.aspx | SCR_014387 | Integrated Islet Distribution Program | 2026-09-03 04:58:15 | 323 | ||||||
|
Centers for Diabetes Translation Research Resource Report Resource Website 1+ mentions |
Centers for Diabetes Translation Research (RRID:SCR_015149) | data or information resource, disease-related portal, organization portal, portal, resource, topical portal | Centers that are part of an integrated program whose cores support and enhance diabetes type II translation research. The CDTRs aim to enhance the efficiency, productivity, effectiveness and multidisciplinary nature of diabetes translation research. | diabetes type ii, diabetes research, translation |
is listed by: NIDDK Information Network (dkNET) is affiliated with: Vanderbilt Center for Diabetes Translation Research is affiliated with: New York Regional Center for Diabetes Translation Research is affiliated with: Chicago Center for Diabetes Translation Research is affiliated with: Georgia Center for Diabetes Translation Research is affiliated with: Michigan Center for Diabetes Translational Research is affiliated with: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases has organization facet: Chicago Center for Diabetes Translation Research has organization facet: New York Regional Center for Diabetes Translation Research has organization facet: Georgia Center for Diabetes Translation Research has organization facet: Health Delivery Systems Center for Diabetes Translational Research has organization facet: Michigan Center for Diabetes Translational Research has organization facet: Vanderbilt Center for Diabetes Translation Research has organization facet: Washington University Center for Diabetes Translation Research |
Diabetes | NIDDK P30RFA-DK15-003 | Available to the research community | SCR_015149 | 2026-09-03 04:58:05 | 1 | ||||||||
|
thesugarscience Resource Report Resource Website 1+ mentions |
thesugarscience (RRID:SCR_020250) | data or information resource, disease-related portal, portal, topical portal | Interactive digital platform helping scientists who study type 1 diabetes connect, collaborate, and gain funding for their best ideas. All volunteer team has received much positive support from the global population of scientists studying type 1 diabetes, as well as from Beyond Type 1, JDRF, and IPITA. Provides curated conversations, events and technology to scientific T1D focused audience. Non profit entity funded by donations and sponsorships with industry and academic partners to provide unique collaborative benefits and programs to researchers in the T1D academic research community. | Type 1 diabetes support, collaborative benefits, programs, T1D academic research community | Type 1 diabetes, Diabetes | Free, Freely available | SCR_020250 | 2026-09-03 04:56:09 | 1 | ||||||||||
|
Common Metabolic Diseases Knowledge Portal Resource Report Resource Website 50+ mentions |
Common Metabolic Diseases Knowledge Portal (RRID:SCR_020937) | CMDKP | data or information resource, data repository, database, disease-related portal, portal, service resource, storage service resource, topical portal | Portal enables browsing, searching, and analysis of human genetic information linked to common metabolic diseases and traits, while protecting integrity and confidentiality of underlying data. Aggregates and analyzes genetic association results, epigenomic annotations, and results of computational prediction methods to provide data, visualizations, and tools in open access portal. | Analyzes genetic association results, aggregates genetic association results, epigenomic annotations, genetic data, epigenomic data |
is listed by: NIDDK Information Network (dkNET) is related to: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is related to: Type 1 Diabetes Knowledge Portal is related to: Human Genetics Amplifier is related to: Common Metabolic Disease Genome Atlas |
Metabolic diseases, Type 1 diabetes, Type 2 diabetes, Cardiovascular disease, Cerebrovascular disease, Sleep disorder, Circadian disorder, Diabetes | Accelerating Medicines Partnership | Free, Available for download, Freely available | SCR_020937 | 2026-09-03 04:57:07 | 66 | |||||||
|
Clinical Islet Transplantation Consortium (CITC) Resource Report Resource Website 1+ mentions |
Clinical Islet Transplantation Consortium (CITC) (RRID:SCR_014385) | CITC, CIT | access service resource, service resource | Network of clinical centers and a data coordinating center established to conduct studies of islet transplantation in patients with type 1 diabetes. | type 1 diabetes, consortium, network, islet transplantation, clinical |
is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Research Resources is listed by: Diabetes Research Centers |
Type 1 diabetes, Diabetes | NIAID ; NIDDK U01 DK070431 |
SCR_014385 | Clinical Islet Transplantation Consortium | 2026-09-03 04:53:02 | 1 | |||||||
|
LANDMark BioBanks Resource Report Resource Website 1+ mentions |
LANDMark BioBanks (RRID:SCR_014534) | biobank, biospecimen repository, data or information resource, data set, material storage repository, service resource, storage service resource | A repository of human tissue samples collected during the LANDMark study (Longitudinal Assessment of Neuropathy in Diabetes using novel ophthalmic markers). The LANDMark Biobank longitudinal dataset contains blood and tissue (skin) samples and matching detailed phenotypic data of three microvascluar complications of type 1 diabetes: neuropathy, nephropathy and retinopathy. | biospecimen repository, data set, type 1 diabetes, biobank, human tissue, landmark study, longitudinal data set, blood, skin, neuropathy, nephropathy, retinopathy | is listed by: NIDDK Information Network (dkNET) | Type 1 diabetes, Diabetes | Available to the research community, Apply to the Tissue Access Committee to access tissue samples | SCR_014534 | 2026-09-03 04:52:49 | 2 | |||||||||
|
Type 1 Diabetes Preclinical Testing Program Resource Report Resource Website |
Type 1 Diabetes Preclinical Testing Program (RRID:SCR_006861) | T1D-PTP, NIDDKT1D-PTP | resource, service resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 22, 2016. Investigator access is provided to the established facilities and expertise needed to extend, enhance and validate preclinical studies of promising new therapeutics in cases where additional preclinical testing is needed to validate potential therapies under disease-specific conditions and in multiple animal models before therapeutics can enter the Type 1 Diabetes Rapid Access to Intervention Development (T1D-RAID) development pipeline. The T1D-RAID program provides resources for pre-clinical development of drugs, natural products, and biologics that will be tested as new therapeutics in type 1 diabetes clinical trials. The T1D-RAID program is not currently accepting applications. The T1D-PTP program currently supports two contracts, which are separate from each other and from the T1D-RAID NCI contract resources, to assist in preclinical development of therapeutics for T1D: * Agents to be tested for Preclinical Efficacy in Prevention or Reversal of Type 1 Diabetes in Rodent Models. Type 1 Diabetes Preclinical Testing Program (T1D-PTP) (NOT-DK-09-006) * Needs for Preclinical Efficacy Testing of Promising Agents to Prevent or Reverse Diabetic Complications (NOT-DK-09-009) The T1D-RAID and T1D-PTP are programs intended to remove the most common barriers to progress in identification and development of new therapies for Type 1 Diabetes. The common goal of these programs is to support and provide for the preclinical work necessary to obtain proof of principle establishing that a new molecule or novel approach will be a viable candidate for expanded clinical evaluation. | testing, therapeutic, clinical, drug, preclinical, therapy, drug development, high-throughput screening, animal model, formulation, pharmacology, toxicology |
is related to: Type 1 Diabetes - Rapid Access to Intervention Development is related to: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Type 1 diabetes, Diabetes | NIDDK | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_152741 | SCR_006861 | Type 1 Diabetes Preclinical Testing Program (T1D-PtP), NIDDKType 1 Diabetes Preclinical Testing Program | 2026-09-03 05:06:18 | 0 | |||||
|
Diabetes Control and Complications Trial Resource Report Resource Website |
Diabetes Control and Complications Trial (RRID:SCR_006805) | DCCT | clinical trial, data or information resource, database, resource | Clinical study that showed that keeping blood glucose levels as close to normal as possible slows the onset and progression of eye, kidney, and nerve diseases caused by diabetes. EDIC is a follow-up study of people who participated in DCCT. The DCCT involved 1,441 volunteers, ages 13 to 39, with type 1 diabetes and 29 medical centers in the United States and Canada. Volunteers had to have had diabetes for at least 1 year but no longer than 15 years. They also were required to have no, or only early signs of, diabetic eye disease. The study compared the effects of standard control of blood glucose versus intensive control on the complications of diabetes. Intensive control meant keeping hemoglobin A1C levels as close as possible to the normal value of 6 percent or less. The A1C blood test reflects a person''''s average blood glucose over the last 2 to 3 months. Volunteers were randomly assigned to each treatment group. DCCT Study Findings * Intensive blood glucose control reduces risk of ** eye disease: 76% reduced risk ** kidney disease: 50% reduced risk ** nerve disease: 60% reduced risk When the DCCT ended, researchers continued to study more than 90 percent of participants. The follow-up study, called Epidemiology of Diabetes Interventions and Complications (EDIC), is assessing the incidence and predictors of cardiovascular disease events such as heart attack, stroke, or needed heart surgery, as well as diabetic complications related to the eye, kidney, and nerves. The EDIC study is also examining the impact of intensive control versus standard control on quality of life. Another objective is to look at the cost-effectiveness of intensive control. EDIC Study Findings * Intensive blood glucose control reduces risk of ** any cardiovascular disease event: 42% reduced risk ** nonfatal heart attack, stroke, or death from cardiovascular causes: 57% reduced risk | blood glucose, adolescent, young human, middle adult human, longitudinal, eye disease, kidney disease, nerve disease, cardiovascular disease, heart attack, stroke, blood pressure, blood lipid, complication |
is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Central Repository is related to: Epidemiology of Diabetes Interventions and Complications is related to: Epidemiology of Diabetes Interventions and Complications is related to: NIDDK Information Network (dkNET) has parent organization: National Diabetes Information Clearinghouse |
Type 1 diabetes, Diabetes | NIDDK | nlx_152798 | SCR_006805 | DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study | 2026-09-03 05:06:29 | 0 | ||||||
|
Longitudinal Study of Elderly Mexican American Health Resource Report Resource Website 1+ mentions |
Longitudinal Study of Elderly Mexican American Health (RRID:SCR_008941) | HEPESE | data or information resource, data set | A dataset of a longitudinal study of over 3,000 Mexican-Americans aged 65 or over living in five southwestern states. The objective is to describe the physical and mental health of the study group and link them to key social variables (e.g., social support, health behavior, acculturation, migration). To the extent possible, the study was modeled after the existing EPESE studies, especially the Duke EPESE, which included a large sample if African-Americans. Unlike the other EPESE studies that were restricted to small geographic areas, the Hispanic EPESE aimed at obtaining a representative sample of community-dwelling Mexican-American elderly residing in Texas, New Mexico, Arizona, Colorado, and California. Approximately 85% of Mexican-American elderly reside in these states and data were obtained that are generalizable to roughly 500,000 older people. The final sample of 3,050 subjects at baseline is comparable to those of the other EPESE studies. Data Availability: Waves I to IV are available through the National Archive of Computerized Data on Aging (NACDA), ICPSR. Also available through NACDA is the ����??Resource Book of the Hispanic Established Populations for the Epidemiologic Studies of the Elderly����?? which offers a thorough review of the data and its applications. All subjects aged 75 or older were interviewed for Wave V and 902 new subjects were added. Hemoglobin A1c test kits were provided to subjects who self-reported diabetes. Approximately 270 of the kits were returned for analyses. Wave V data are being validated and reviewed. A tentative timeline for the archiving of Wave V data is November 2006. Wave VI interviewing and data collection is scheduled to begin in Fall 2006. * Dates of Study: 1993-2006 * Study Features: Longitudinal, Minority oversamples, Anthropometric Measures * Sample Size: ** 1993-4: 3,050 (Wave I) ** 1995-6: 2,438 (Wave II) ** 1998-9: 1,980 (Wave III) ** 2000-1: 1,682 (Wave IV) ** 2004-5: 2,073 (Wave V) ** 2006-7: (Wave VI) Links: * ICPSR Wave 1: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/2851 * ICPSR Wave 2: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/3385 * ICPSR Wave 3: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/4102 * ICPSR Wave 4: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/4314 * ICPSR Wave 5: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/25041 * ICPSR Wave 6: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/29654 | longitudinal, minority, anthropometric measure, mexican-american, questionnaire, physical health, mental health, functional impairment, risk factor, mortality, morbidity, late adult human, southwestern united states, arizona, california, colorado, new mexico, texas, iadl, adl, living arrangement, blood pressure, social support, family, stress, life event, employment, health, acculturation, religion, social involvement, global health rating, self-esteem, medical condition, performance-oriented mobility assessment, ces-d, height, weight, cognition, health care services utilization, behavior, income, financial strain, medication, insurance coverage, migration, interview, hemoglobin a1c test, demographics, ethnicity, health behavior, health problem, health status, hispanic, latino american, life expectancy, quality of life |
is listed by: Inter-university Consortium for Political and Social Research (ICPSR) is related to: Established Populations for Epidemiologic Studies of the Elderly has parent organization: University of Texas Medical Branch at Galveston has parent organization: National Archive of Computerized Data on Aging (NACDA) |
Aging, Diabetes | NIA RO1 AG10939 | Public | nlx_151848 | http://www.utmb.edu/pmch/hepese/, http://pmch.utmb.edu/sponsoredprograms/sp_populationhealth.aspxhttp://www.utexas.edu/cola/centers/prc/research/profiles/angellongitudinal/ | SCR_008941 | Longitudinal Study of Mexican-American Elderly Health (The Hispanic EPESE), Hispanic Established Populations for Epidemiologic Studies of the Elderly, Longitudinal Study of Mexican-American Elderly Health, Hispanic EPESE | 2026-09-03 05:06:24 | 1 | ||||
|
ACCORD Resource Report Resource Website 100+ mentions |
ACCORD (RRID:SCR_009015) | ACCORD | clinical trial, resource | Study testing whether strict glucose control lowers the risk of heart disease and stroke in adults with type 2 diabetes. In addition the study is exploring: 1) Whether in the context of good glycemic control the use of different lowering lipid drugs will further improve these outcomes and 2) If strict control of blood pressure will also have additional beneficial effects on reducing cardiovascular disease. The design was a randomized, multicenter, double 2 X 2 factorial trial in 10,251 patients with type 2 diabetes mellitus. It was designed to test the effects on major CVD events of intensive glycemia control, of fibrate treatment to increase HDL-cholesterol and lower triglycerides (in the context of good LDL-C and glycemia control), and of intensive blood pressure control (in the context of good glycemia control), each compared to an appropriate control. All 10,251 participants were in an overarching glycemia trial. In addition, one 2 X 2 trial addressed the lipid question in 5,518 of the participants and the other 2 X 2 trial addressed the blood pressure question in 4,733 of the participants. The glycemia trial was terminated early due to higher mortality in the intensive compared with the standard glycemia treatment strategies. The results were published in June 2008 (N Eng J Med 2008;358:2545-59). Study-delivered treatment for all ACCORD participants was stopped on June 30, 2009, and the participants were assisted as needed in transferring their care to a personal physician. The lipid and blood pressure results (as well as the microvascular outcomes and eye substudy results) were published in 2010. All participants are continuing to be followed in a non-treatment observational study. | middle adult human, late adult human, glycemic control, lowering lipid drug, blood pressure, lipid, clinical |
is related to: NIDDK Information Network (dkNET) has parent organization: National Heart Lung and Blood Institute |
Cardiovascular disease, Stroke, Type 2 diabetes, Diabetes, Aging | NHLBI ; NIDDK ; NEI ; CDC ; NIA |
PMID:23490598 PMID:23253271 PMID:23238658 PMID:22723583 PMID:22646230 |
nlx_152746 | SCR_009015 | Action to Control Cardiovascular Disease Risk in Diabetes | 2026-09-03 05:06:11 | 180 | |||||
|
Boston Area Diabetes Endocrinology Research Center Metabolic Physiology and Energy Balance Core Facility Resource Report Resource Website |
Boston Area Diabetes Endocrinology Research Center Metabolic Physiology and Energy Balance Core Facility (RRID:SCR_008293) | access service resource, core facility, service resource | Core in BADERC that provides services in consultation and teaching, use of DEXA scanner for determination of body fat and/or bone density, and use of Coulter Counter to measure cell number and cell size distribution. | animal physiology, metabolic physiology |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: Harvard University; Cambridge; United States is organization facet of: Boston Area Diabetes Endocrinology Research Center |
Diabetes | NIDDK P30 DK057521 | Available to the research community, Fee for service | nlx_156297 | http://www.baderc.org/cores/metabolicCore.html | http://www.baderc.org/cores/metabolicCore.html | SCR_008293 | Boston Area Diabetes Endocrinology Research Center Metabolic Physiology | 2026-09-03 05:06:22 | 0 | ||||
|
Joslin Diabetes Center Flow Cytometry Core Facility Resource Report Resource Website 500+ mentions |
Joslin Diabetes Center Flow Cytometry Core Facility (RRID:SCR_009878) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides cell sorting and flow cytometry services. Specific services include cell analysis, large object sorting,magnetic cell enrichment, and automatic cell counting. | flow cytometry, flow cytometry service, cell sorting, cell analysis |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: Joslin Diabetes Center is organization facet of: Joslin Diabetes Center |
Diabetes | NIDDK P30DK036836 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_156348 | SCR_009878 | 2026-09-03 05:06:16 | 590 | |||||||
|
Joslin Diabetes Center Animal Physiology Core Facility Resource Report Resource Website 500+ mentions |
Joslin Diabetes Center Animal Physiology Core Facility (RRID:SCR_009876) | access service resource, core facility, resource, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides technically advanced physiological evaluation of metabolism in diabetes, obesity, and their associated complications in rodents for DRC investigators and outside users. It also provides training of investigators and trainees in several physiological procedures. | physiological evaluation, diabetes metabolism, obesity metabolism, rodent research, diabetes rodent research, physiological procedure training |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: Joslin Diabetes Center is organization facet of: Joslin Diabetes Center |
Diabetes | NIDDK P30DK036836 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_156346 | SCR_009876 | 2026-09-03 05:06:32 | 590 | |||||||
|
Joslin Diabetes Center Advanced Microscopy Core Facility Resource Report Resource Website 500+ mentions |
Joslin Diabetes Center Advanced Microscopy Core Facility (RRID:SCR_009875) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for performing specific morphological procedures, providing training and access to equipment, maintaining the specialized microscopes, and giving advice and interpretation. | morphology service, training service, microscope maintanence, |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: Joslin Diabetes Center is organization facet of: Joslin Diabetes Center |
Diabetes | NIDDK P30DK036836 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_156345 | SCR_009875 | 2026-09-03 05:06:49 | 590 | |||||||
|
Joslin Diabetes Center Advanced Genomics and Genetics Core Facility Resource Report Resource Website 500+ mentions |
Joslin Diabetes Center Advanced Genomics and Genetics Core Facility (RRID:SCR_009873) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for genetic and genomic analysis, including DNA extraction from blood, access to DNA collections from the Core?s repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR. | gene analysis, genome analysis, dna extraction, gene expression service |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: Joslin Diabetes Center is organization facet of: Joslin Diabetes Center |
Diabetes | NIDDK P30DK036836 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_156350 | SCR_009873 | 2026-09-03 05:06:42 | 590 | |||||||
|
HMS Human Sample Procurement Core Facility Resource Report Resource Website |
HMS Human Sample Procurement Core Facility (RRID:SCR_009797) | access service resource, core facility, service resource |
Core facility that provides the following services: Autoantibody determination, HLA typing and Genotyping for the best recognized susceptibility loci (INS, PTPN22, CTLA4). The Human Sample Procurement Core will support translational research endeavors within the JDRF Center by providing the Center''s laboratories access to well-characterized blood samples from patients with diabetes at different stages of the disease. This availability will greatly facilitate the translational exploration of concepts and targets emerging from the basic research projects. Individuals with T1D (recent onset, long-standing Type-1 diabetes) and matched controls (healthy or T2D) will be recruited from the patient population at the Joslin Diabetes Center and neighboring institutions. The Core will perform and record a basic characterization of patients and their samples. This analysis will include a thorough evaluation of clinical characteristics from a diabetes and autoimmune standpoint, and an immunogenetic workup (outsourced to Joslin or other cores): autoantibody determination, HLA typing and genotyping for the best recognized susceptibility loci (INS, PTPN22, CTLA4). A relational database will be adapted to record all patient information, copies of which will be provided in a de-identified manner to the investigators. |
immunoassay, genotyping assay |
is listed by: Eagle I has parent organization: Harvard Medical School; Massachusetts; USA |
Type 1 diabetes, Type 2 diabetes, Diabetes | nlx_156265 | http://citdh.org/mock_new2_content.html | SCR_009797 | 2026-09-03 05:06:23 | 0 | ||||||||
|
HMS Genetically Modified NOD Mouse Core Facility Resource Report Resource Website 1+ mentions |
HMS Genetically Modified NOD Mouse Core Facility (RRID:SCR_009796) | access service resource, core facility, service resource |
Core facility that provides the following services: Maintainence and dissemination of transgenic and mutant mice. The Genetically Modified NOD Mouse Core provides Center investigators, as well as researchers elsewhere, with access to transgenic and mutant lines derived from the NOD mouse model: some will be generated within the Core; others are established lines of proven experimental value that are maintained in the Core. The Core will construct transgenic mice in strains that have a high susceptibility to diabetes (in particular in the NOD line). This includes trangenesis by conventional pronuclear injection or by delivery of RNAi cassettes on lentiviral vectors. The Core will also provide a panel of existing transgenic and mutant lines. These lines are chosen because of their established interest in allowing the dissection of immunological tolerance in Type 1 Diabetes, and in response to Center investigator needs. |
laboratory animal care |
is listed by: Eagle I has parent organization: Harvard Medical School; Massachusetts; USA |
Type 1 Diabetes, Diabetes | nlx_156264 | http://cbdm.hms.harvard.edu/Transgenics/mice_available.html, http://immdiv.hms.harvard.edu | SCR_009796 | 2026-09-03 05:06:26 | 1 | ||||||||
|
Jackson Heart Study Resource Report Resource Website 50+ mentions |
Jackson Heart Study (RRID:SCR_009902) | access service resource, core facility, service resource | The JHS is the largest single-site longitudinal, population-based, cohort study of 5,302 persons initiated in the fall of 2000 to prospectively investigate the determinants of CVD among African Americans in the Jackson, MS metropolitan statistical area. The JHS investigates the various genotype and phenotype factors that affect high blood pressure, heart disease, strokes, diabetes and other important diseases in African Americans. The primary objective of the Jackson Heart Study is to investigate the causes of cardiovascular disease (CVD) in African Americans to learn how to best prevent this group of diseases in the future. More specific objectives include: 1. Identification of factors, which influence the development, and worsening of CVD in African Americans, with an emphasis on manifestations related to high blood pressure (such as remodeling of the left ventricle of the heart, coronary artery disease, heart failure, stroke and disorders affecting the blood vessels of the kidney). 2. Building research capabilities in minority institutions at the undergraduate and graduate level by developing partnerships between minority and majority institutions and enhancing participation of minority investigators in large-scale epidemiologic studies. 3. Attracting minority students to and preparing them for careers in health sciences. |
is listed by: Eagle I is related to: A Whole Genome Admixture Scan for Type 2 Diabetes in African Americans has parent organization: Jackson State University; Mississippi; USA |
Diabetes, Cardiovascular disease, Kidney disease, Respiratory disease | nlx_156367 | SCR_009902 | 2026-09-03 05:06:43 | 71 | ||||||||||
|
Penn Diabetes Research Center Radioimmunoassay and Biomarkers Core Facility Resource Report Resource Website |
Penn Diabetes Research Center Radioimmunoassay and Biomarkers Core Facility (RRID:SCR_010028) | access service resource, core facility, service resource | Core which offers high quality immunoassay services to basic, translational, and clinical investigators performing diabetes and related metabolic disease research. The core also provides consultation and training and education services. | assay service, diabetes research, immunoassay consultation |
is listed by: Eagle I is listed by: NIDDK Information Network (dkNET) has parent organization: University of Pennsylvania; Philadelphia; USA has parent organization: Penn Diabetes Research Center is organization facet of: Penn Diabetes Research Center |
Diabetes | NIDDK P30DK19525 | Restricted | nlx_156498 | SCR_010028 | Penn Diabetes Research Center Radioimmunoassay and Biomarkers Core | 2026-09-03 05:06:40 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
